BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29266071)

  • 1. ACOG Committee Opinion No. 727 Summary: Cascade Testing: Testing Women For Known Hereditary Genetic Mutations Associated With Cancer.
    Obstet Gynecol; 2018 Jan; 131(1):194-195. PubMed ID: 29266071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACOG Committee Opinion No. 727: Cascade Testing: Testing Women for Known Hereditary Genetic Mutations Associated With Cancer.
    Committee on Gynecologic Practice
    Obstet Gynecol; 2018 Jan; 131(1):e31-e34. PubMed ID: 29266077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary Cancer Syndromes and Risk Assessment: ACOG COMMITTEE OPINION SUMMARY, Number 793.
    Obstet Gynecol; 2019 Dec; 134(6):1366-1367. PubMed ID: 31764755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary Cancer Syndromes and Risk Assessment: ACOG COMMITTEE OPINION, Number 793.
    Obstet Gynecol; 2019 Dec; 134(6):e143-e149. PubMed ID: 31764758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cascade genetic testing for hereditary cancer syndromes: a review of barriers and breakthroughs.
    Levine R; Kahn RM; Perez L; Brewer J; Ratner S; Li X; Yeoshoua E; Frey MK
    Fam Cancer; 2024 Jun; 23(2):111-120. PubMed ID: 38530571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper.
    Randall LM; Pothuri B; Swisher EM; Diaz JP; Buchanan A; Witkop CT; Bethan Powell C; Smith EB; Robson ME; Boyd J; Coleman RL; Lu K
    Gynecol Oncol; 2017 Aug; 146(2):217-224. PubMed ID: 28596016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying hereditary cancer: genetic counseling and cancer risk assessment.
    Lewis KM
    Curr Probl Cancer; 2014; 38(6):216-25. PubMed ID: 25432528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing for Hereditary Predisposition in Patients with Gynecologic Cancers, Quo Vadis?
    Mitchell G; Schrader KA
    Surg Pathol Clin; 2016 Jun; 9(2):301-6. PubMed ID: 27241110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gynecologic Pathology.
    Clarke BA; McCluggage WG
    Surg Pathol Clin; 2016 Jun; 9(2):ix-x. PubMed ID: 27241113
    [No Abstract]   [Full Text] [Related]  

  • 10. Strategies for clinical implementation of screening for hereditary cancer syndromes.
    Heald B; Marquard J; Funchain P
    Semin Oncol; 2016 Oct; 43(5):609-614. PubMed ID: 27899194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cascade testing for hereditary cancer in Singapore: how population genomics help guide clinical policy.
    Caeser R; Chiang J; Tan ES; Tai ES; Ngeow J
    Fam Cancer; 2024 Jun; 23(2):133-140. PubMed ID: 38662262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Committee Opinion No. 693 Summary: Counseling About Genetic Testing and Communication of Genetic Test Results.
    Obstet Gynecol; 2017 Apr; 129(4):771-772. PubMed ID: 28333813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary Cancers in Gynecology: What Physicians Should Know About Genetic Testing, Screening, and Risk Reduction.
    Ring KL; Modesitt SC
    Obstet Gynecol Clin North Am; 2018 Mar; 45(1):155-173. PubMed ID: 29428283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary breast-ovarian cancer: clinical findings and medical management.
    Marshall M; Solomon S
    Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing for cancer susceptibility genes in children.
    Laxova R
    Adv Pediatr; 1999; 46():1-40. PubMed ID: 10645460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.
    Wilson RD; De Bie I; Armour CM; Brown RN; Campagnolo C; Carroll JC; Okun N; Nelson T; Zwingerman R; Audibert F; Brock JA; Brown RN; Campagnolo C; Carroll JC; De Bie I; Johnson JA; Okun N; Pastruck M; Vallée-Pouliot K; Wilson RD; Zwingerman R; Armour C; Chitayat D; De Bie I; Fernandez S; Kim R; Lavoie J; Leonard N; Nelson T; Taylor S; Van Allen M; Van Karnebeek C
    J Obstet Gynaecol Can; 2016 Aug; 38(8):742-762.e3. PubMed ID: 27638987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic counselling and genetic testing in hereditary gastrointestinal cancer syndromes.
    Raymond VM; Everett JN
    Best Pract Res Clin Gastroenterol; 2009; 23(2):275-83. PubMed ID: 19414152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common hereditary cancer syndromes.
    Greco KE; Mahon S
    Semin Oncol Nurs; 2004 Aug; 20(3):164-77. PubMed ID: 15491026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Committee Opinion No. 693: Counseling About Genetic Testing and Communication of Genetic Test Results.
    Obstet Gynecol; 2017 Apr; 129(4):e96-e101. PubMed ID: 28333821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.